Lumida
/LFST
⌘K
LifeStance Health Group Inc

LifeStance Health Group Inc

LFST
$12.97USD-0.23%-0.03 today

MARKET CAP

5.0B

P/E (TTM)

324.3x

FWD P/E

DAY RANGE

$13 – $13

52W RANGE

$5
$13

AI Summary

Stalk
Sell NowMedium

Sell now into the marginal new‐high resistance area; the Bullish Exhaustion pattern combined with extreme overbought conditions and a Stage 3 distribution context suggest a high probability pullback or reversal, warranting bearish participation.

  • 26% YoY revenue growth to $435M in Q2, net income rebounded to $24M.
  • Raised 2026 revenue guidance to $1.685–1.725B, implying ~20% growth.
  • Elevated volatility may cause large stock price swings and deter investors.
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$667.5M$859.5M$1.1B$1.3B$1.4B
YoY %+28.8%+22.8%+18.5%+13.9%
P / Sales4.7x1.9x2.7x2.2x1.9x
EV / Sales5.0x2.6x3.3x2.6x2.2x
Gross Profit, Adj.$667.5M$237.0M$302.1M$402.4M$461.1M
YoY %-64.5%+27.5%+33.2%+14.6%
Margin %100.0%27.6%28.6%32.2%32.4%
EV / Gross Profit5.0x9.3x11.6x8.2x6.9x
EBITDA, Adj.$-232.2M$-141.2M$-108.9M$38.1M$78.8M
YoY %+39.2%+22.9%+135.0%+106.5%
Margin %-34.8%-16.4%-10.3%3.0%5.5%
EV / EBITDA-14.4x-15.6x-32.2x86.8x40.5x
EBIT$-286.4M$-210.4M$-189.3M$-32.8M$24.0M
YoY %+26.5%+10.0%+82.7%+173.2%
Margin %-42.9%-24.5%-17.9%-2.6%1.7%
EV / EBIT-11.7x-10.4x-18.5x-101.0x132.7x
Net Income$-343.9M$-215.6M$-186.3M$-57.4M$9.7M
YoY %+37.3%+13.6%+69.2%+116.8%
Net Margin-51.5%-25.1%-17.6%-4.6%0.7%
EPS (GAAP)-$1.05-$0.61-$0.51-$0.15$0.02
YoY %+41.9%+16.4%+70.6%+113.3%